Dattner A M, Mann D L, Levis W R
J Invest Dermatol. 1979 Sep;73(3):246-9. doi: 10.1111/1523-1747.ep12514334.
Human lymphocytes from dinitrochlorobenzene (DNCB)-sensitized human subjects primed in first culture with dinitrophenylated-antigens yield a population of cells which respond in an accelerated manner to the same or similar antigen in second culture. Using this "clonal priming" approach, we have demonstrated that such a primed population showed maximal proliferative response to dinitrophenylated autologous cells. These DNP primed clones also showed responses to some dinitrophenylated allogeneic leukocytes. The magnitude of the accelerated blastogenic response with allogeneic leukocytes varied in most instances in relation to the degree of sharing of HLA-A, B, and DRw antigens with the original autologous stimulator. These findings show that the self-specific factors recognized in conjunction with the dinitrophenyl antigen are closely but not invariably associated with established major histocompatibility (MHC)-associated serologic typing results. While DNP primed clones fail to respond to unmodified autologous leukocytes, they often show significant responses to unmodified allogeneic leukocytes. If such accelerated responses to unmodified allogeneic leukocytes are not the result of nonspecific activation of allogeneic responding lymphocyte clones, these findings further indicate that DNP modified self can resemble some alloantigens.
来自经二硝基氯苯(DNCB)致敏的人类受试者的淋巴细胞,在初次培养中用二硝基苯基化抗原进行致敏后,会产生一群细胞,这些细胞在二次培养中对相同或相似抗原会以加速的方式作出反应。利用这种“克隆致敏”方法,我们已经证明,这样一个致敏群体对二硝基苯基化自体细胞表现出最大的增殖反应。这些二硝基苯基(DNP)致敏克隆也对一些二硝基苯基化同种异体白细胞有反应。在大多数情况下,同种异体白细胞引发的加速增殖反应的强度与与原始自体刺激物在HLA - A、B和DRw抗原的共享程度有关。这些发现表明,与二硝基苯基抗原结合识别的自身特异性因子与既定的主要组织相容性(MHC)相关血清学分型结果密切相关,但并非总是如此。虽然DNP致敏克隆对未修饰的自体白细胞无反应,但它们通常对未修饰的同种异体白细胞有显著反应。如果对未修饰的同种异体白细胞的这种加速反应不是同种异体反应性淋巴细胞克隆非特异性激活的结果,那么这些发现进一步表明,DNP修饰的自身可能类似于一些同种异体抗原。